CompletedPhase 2NCT00883129
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Studying Diffuse cutaneous systemic sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Michael Roth
- Principal Investigator
- Donald P. Tashkin, MDUniversity of California, Los Angeles
- Intervention
- Mycophenolate mofetil(drug)
- Enrollment
- 142 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2015
Study locations (14)
- David Geffen School of Medicine at UCLA, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- National Jewish Health, Denver, Colorado, United States
- Georgetown University School of Medicine, Washington D.C., District of Columbia, United States
- Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
- University of Illinois at Chicago, College of Medicine, Chicago, Illinois, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- Boston University School of Medicine, Boston, Massachusetts, United States
- University of Michigan Medical School, Ann Arbor, Michigan, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- University of Texas Medical School at Houston, Houston, Texas, United States
- University of Utah, Salt Lake City, Utah, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Hoffmann-La Roche
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00883129 on ClinicalTrials.govOther trials for Diffuse cutaneous systemic sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07473154Controlling Hyperactive Immunity With Long-lived LymphocytesQuell Therapeutics Limited
- RECRUITINGPHASE1, PHASE2NCT06947473Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.Beijing GoBroad Hospital
- RECRUITINGPHASE2NCT05029336Autologous Stem Cell Transplant (ASCT) for Autoimmune DiseasesStephan Grupp MD PhD
- RECRUITINGPHASE2NCT07047690A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisGalderma R&D
- RECRUITINGPHASE2NCT07287670EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)Mediar Therapeutics
- RECRUITINGNCT07256418Transcriptomic Study of Cutaneous Fibroblasts in SclerodermaCentre Hospitalier Universitaire Dijon
- RECRUITINGPHASE1NCT07295847A Study of AZD0120 in Autoimmune DiseasesAstraZeneca
- RECRUITINGNANCT07292961Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With SclerodermaHacettepe University